Data / Form D filings / Solace Lifesciences, Inc.
Solace Lifesciences, Inc.: Form D filings
Solace Lifesciences, Inc., a health care company in Wilmington, DE, filed 4 Form D notices with the SEC between 2010 and 2018. The latest, on December 7, 2018, reports an offering of $5 million with nothing sold yet.
Find out what Solace Lifesciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 SILVERSIDE ROAD #7, Wilmington, DE, 19809
- Phone
- (877) 668-2256
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1502380
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Dec 14, 2017 | Amendment | $4,000,000 | $1,551,401 | $2,448,599 | 43 | Jun 2, 2015 | sec.gov |
| May 1, 2015 | New notice | $4,000,000 | $0 | $4,000,000 | 0 | Yet to occur | sec.gov |
| Oct 6, 2010 | New notice | $2,000,000 | $50,000 | $1,950,000 | 2 | Sep 27, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James M Poole | Executive Officer, Director | |
| Stephen G Kujawa | Director | |
| David G Pilzner | Director | |
| Christopher G Gross | Executive Officer, Director | |
| Garrett G Holloway | Director |
Other health care companies in Delaware that filed recently
- GiftWellSoon, LLC $75,000 · Nov 6, 2026
- ChemoMouthpiece, LLC $400,000 · Oct 30, 2026
- Oncology AI Fleet, Inc. offering · Oct 28, 2026
- Hygia Technologies, Inc. $125,000 · Oct 13, 2026
- Vantage Health, Inc. $2.5 million · Oct 2, 2026
- DSIpharma, Inc. $951,250 · Oct 2, 2026
- Meca Industries Corp $37,500 · Sep 21, 2026
- Glauc Inc. $50,000 · Sep 15, 2026
- Amen Health Inc $100,510 · Aug 14, 2026
Every Form D from the week of Dec 3, 2018 · All recent filings in Delaware · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Solace Lifesciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.